Susan Faja, PhD

Biomarker Research Lead

Boston Children's Hospital (BCH)

Dr. Faja has over two decades of experience conducting research with autism including clinical trials and longitudinal investigations of early symptom development in autism as well as intervention and assessment development into young adulthood. Dr. Faja has used EEG/ERP, eye-tracking, and psychophysiological measures in the context of autism clinical trials and has integrated these biomarkers with behavioral and clinical measures. As a clinical neuroscientist with a license in psychology, Dr. Faja is positioned to ensure optimal biomarker and quantitative data acquisition as well as the positive participant and family experience required to ensure longitudinal measurement.